hello, I just wanted to tell you that there is a new treatment that is now in phase I, that seems to give good results with HER2- tumors. It is given in combination with taxol, and it is an inhibitor of the epidermal growth factor receptors 1, 2 and 3, it is called AZD 8931 (Astra Zeneca). I have been included in the phase I/II in Barcelona, there will be a phase II only for breast cancer, and there will be four study locations in the UK
from the webpage:
Research Site Not yet recruiting
Surrey, United Kingdom
Research Site Not yet recruiting
Glasgow, United Kingdom
Research Site Not yet recruiting
Leicester, United Kingdom
Research Site Not yet recruiting
Nottingham, United Kingdom
Research Site Not yet recruiting
Cardiff, United Kingdom
more information at clinicaltrials.gov/ct2/show/study/NCT00900627?term=AZD+8931&rank=1&show_locs=Y#locn
Please ask me if you like to know any information
xx
sabrina